{
    "code": "60000992",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60000992",
    "time": "2022-07-29 08:53:58",
    "許可證字號": "衛部菌疫輸字第000992號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/08\/26",
    "發證日期": "104\/08\/26",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA06000099207",
    "中文品名": "可善挺凍晶乾粉注射劑150毫克",
    "英文品名": "Cosentyx 150 mg Powder for Solution for Injection",
    "適應症": "1. 斑塊性乾癬：治療適合接受全身性治療的中至重度斑塊性乾癬成人患者。\r\n2. 乾癬性關節炎：治療患有活動性乾癬性關節炎的成人病人。可單獨使用或與methotrexate併用。\r\n3. 中軸性脊椎關節炎 (Axial spondyloarthritis, axSpA)\r\n  (1) 僵直性脊椎炎(Ankylosing spondylitis, AS)：治療活動性僵直性脊椎炎成人病患。\r\n  (2) 無放射影像確認之中軸性脊椎關節炎(Non-radiographic axial spondyloarthritis，簡稱nr-axSpA) : 適用於治療嚴重活動性無放射影像確認之中軸性脊椎關節炎且符合下列所有條件的成人病人：\r\n   甲、對非類固醇抗發炎藥物(NSAID)治療反應不佳或無法耐受。\r\n   乙、其C反應蛋白(C-reactive protein，簡稱CRP)濃度升高。\r\n   丙、核磁共振造影(MRI)檢查證據顯示有發炎的客觀跡象。\r\n   丁、HLA-B27陽性。",
    "劑型": "247凍晶乾粉注射劑",
    "包裝": "150毫克玻璃小瓶裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "109\/08\/26",
    "主成分略述": "Secukinumab",
    "限制項目": "02輸　入 51免除銜接性臨床試驗",
    "申請商名稱": "0924601100  台灣諾華股份有限公司",
    "申請商地址": "台北市中山區民生東路三段2號8樓",
    "主製造廠": [
        {
            "製造廠名稱": "FCH0088000  NOVARTIS PHARMA STEIN AG",
            "製造廠廠址": "SCHAFFHAUSERSTRASSE CH-4332 STEIN, SWITZERLAND",
            "製造廠公司地址": "CH-4002,BASEL,SWITZERLAND",
            "製造廠國別": "SWITZERLAND",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FCH0088500  NOVARTIS PHARMA. AG",
            "製造廠廠址": "LICHTSTRASSE 35, 4056 BASEL, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "許可證持有者"
        },
        {
            "製造廠名稱": "FFR0220000  NOVARTIS PHARMA S.A.S.",
            "製造廠廠址": "8, RUE DE L&#39;INDUSTRIE, F-68330 HUNINGUE, FRANCE",
            "製造廠公司地址": "",
            "製造廠國別": "FRANCE",
            "製程": "原料藥製造廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200090100",
            "成分名稱": "Secukinumab",
            "含量描述": "",
            "含量": "150.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "(重新排版)中文仿單擬稿_Cosentyx Solution_TWI-120522_2021-PSB.GLC-1251-s (完稿)-111-05-25.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000992&Seq=010&Type=9"
        },
        {
            "title": "Cosentyx凍晶乾粉注射劑_carton-104-10-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000992&Seq=001&Type=8"
        }
    ]
}